Diabetes regulated anti-inflammatory lncRNA is overexpressed in triple-negative breast cancer and predicts chemoresistance and tumor recurrence

Diabetes regulated anti-inflammatory lncRNA (DRAIR) has been characterized as a critical player in type 2 diabetes mellitus. However, its role in other human diseases is unclear. Our preliminary sequencing analysis revealed an altered DRAIR level in triple-negative breast cancer (TNBC). We then expl...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Peng, Peng, Wei, Peng, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9276054/
https://www.ncbi.nlm.nih.gov/pubmed/35609326
http://dx.doi.org/10.1080/21655979.2022.2068821

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9276054/
https://www.ncbi.nlm.nih.gov/pubmed/35609326
http://dx.doi.org/10.1080/21655979.2022.2068821

Ejemplares similares